Spondyloarthritis (SpA) is a leading cause of musculoskeletal morbidity worldwide, disproportionately affecting young individuals in their most productive years.1 Disparities in access, delayed diagnosis (global average of 6.7 years2), and variations in treatment availability remain critical challenges, both globally and particularly across North, Central, and South America.
No takes yet. Share an insight, caveat, or question.
Bittar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: